Eurocine Vaccines discloses half-year report for July – December 2022
Eurocine Vaccines AB (publ) (“Eurocine Vaccines” or the “Company”) hereby discloses the half-year report for July to December 2022. Below is a summary of the report. The full report is available on Eurocine Vaccines’ website and as an attachment. 2022-10-01– 2022-12-31 (second quarter) · Results after tax for the quarter amounted to -6.2 MSEK (-5.3 MSEK) · Revenues for the quarter amounted to 1 KSEK (0 KSEK) · Earnings per share for the quarter amounted to -0.222 SEK (-0.373 SEK) 2022-07-01 – 2022-12-31 (first six months) · Results